BioHarvest Sciences Inc. (NASDAQ:BHST) Sees Large Increase in Short Interest

BioHarvest Sciences Inc. (NASDAQ:BHST) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totaling 64,005 shares, a growth of 92.8% from the December 15th total of 33,198 shares. Based on an average daily trading volume, of 54,486 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.4% of the company’s stock are sold short. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 54,486 shares, the days-to-cover ratio is presently 1.2 days.

Institutional Trading of BioHarvest Sciences

A hedge fund recently raised its stake in BioHarvest Sciences stock. True North Advisors LLC lifted its holdings in BioHarvest Sciences Inc. (NASDAQ:BHST) by 676.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 168,013 shares of the company’s stock after acquiring an additional 146,365 shares during the quarter. True North Advisors LLC owned approximately 1.02% of BioHarvest Sciences worth $1,581,000 at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

BHST has been the topic of several analyst reports. Wall Street Zen upgraded shares of BioHarvest Sciences to a “hold” rating in a research note on Saturday, October 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of BioHarvest Sciences in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $14.50.

BioHarvest Sciences Price Performance

NASDAQ BHST opened at $4.88 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.02 and a debt-to-equity ratio of 0.30. The company has a fifty day simple moving average of $5.89 and a 200 day simple moving average of $7.83. The company has a market cap of $80.13 million, a P/E ratio of -7.18 and a beta of 1.12. BioHarvest Sciences has a 1 year low of $4.72 and a 1 year high of $12.80.

BioHarvest Sciences (NASDAQ:BHST) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). BioHarvest Sciences had a negative return on equity of 1,041.86% and a negative net margin of 36.33%.The business had revenue of $9.07 million during the quarter, compared to analysts’ expectations of $9.11 million. On average, sell-side analysts predict that BioHarvest Sciences will post -0.8 EPS for the current year.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets.